➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKinsey
Harvard Business School
Medtronic
Johnson and Johnson

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Dicyclomine hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for dicyclomine hydrochloride and what is the scope of patent protection?

Dicyclomine hydrochloride is the generic ingredient in four branded drugs marketed by Allergan, Lannett, Mylan, Pioneer Pharms, Sun Pharm Industries, Watson Labs, West Ward, Akorn Inc, Am Regent, Custopharm Inc, Dr Reddys, Fosun Pharma, Fresenius Kabi Usa, Nexus Pharms, Slate, Sungen Pharma, West-ward Pharms Int, Aptalis Pharma Us, Alpharma Us Pharms, Generics, Hikma, and Hikma Pharms, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for dicyclomine hydrochloride. Forty suppliers are listed for this compound.

Summary for dicyclomine hydrochloride
Pharmacology for dicyclomine hydrochloride
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for dicyclomine hydrochloride

US Patents and Regulatory Information for dicyclomine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 084285-001 Approved Prior to Jan 1, 1982 AB RX No Yes   Start Trial   Start Trial   Start Trial
Sun Pharm Industries DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 084505-001 Oct 21, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Generics DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride SYRUP;ORAL 040169-001 Mar 24, 2005 AA RX No Yes   Start Trial   Start Trial   Start Trial
Lannett DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride TABLET;ORAL 040230-001 Feb 26, 1999 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride TABLET;ORAL 085223-001 Jul 30, 1986 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKinsey
Harvard Business School
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.